Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts

Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Latest Articles

  • Open Access
    Genetic susceptibility, environmental risk factors, and incident gastric cancer risk among individuals with different Helicobacter pylori infection status: a population-based study
    Hengmin Xu, Hui Ma, Yuxin Wang, Xinling Wang, Xuan Han, Wenjing Zhao, Yang Zhang, Tong Zhou, Jingying Zhang, Weicheng You, Wenqing Li and Kaifeng Pan
    Cancer Biology & Medicine July 2026, 20260145; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0145
  • Open Access
    The conditional promise of dual-epitope HER2 antibody-drug conjugates in breast cancer
    Ruoqing Wang, Shuhao Jiang, Qun Zhang and Junjie Li
    Cancer Biology & Medicine July 2026, 20260277; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0277
  • Open Access
    Vitamin D potentiates STING agonist-induced antitumor immunity in NSCLC
    Ke Li, Guichao Liu, Wenhui Yuan, Xinhai Zhu and Peng Li
    Cancer Biology & Medicine July 2026, 20260211; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0211
  • Open Access
    Dietary restriction during active cancer therapy is associated with improved treatment response: a systematic review and meta-analysis
    Kajal Agrawal, Dominic Shao Yong Goh, Ee Chern Ng, Shyn Yi Tan, Carlos Cifuentes-González, Jason Xing Kang, William K. K. Wu, Rashid N. S. Lui, Rupesh Agrawal, Yusuf Ali and Sunny H. Wong
    Cancer Biology & Medicine July 2026, 20250841; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0841
  • Open Access
    Exosomal B7H3 drives immunosuppression and serves as a biomarker for PD-1 blockage response in head and neck squamous cell carcinoma
    Wen Wang, Chulong Xie, Juncong Luo, Leru Kuang, Yihong Wu, Nini Li, Xiaoli Liu, Xiaoyu Feng, Zizi Li, Zhanyu Li, Hongyu Zhang, Jiaoping Mi and Qi Zeng
    Cancer Biology & Medicine July 2026, 20250835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0835
  • Open Access
    NSAIDs for PI3K-altered head and neck cancer: a biomarker-driven therapeutic opportunity
    Jovanka Gencel-Augusto, Daniel E. Johnson and Jennifer R. Grandis
    Cancer Biology & Medicine July 2026, 20260202; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0202
View more latest articles

Cover Story

Current issue

Cancer Biology & Medicine: 23 (6)
Cancer Biology & Medicine
Vol. 23, Issue 6
15 Jun 2026
  • Table of Contents
  • Index by author

Submit

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
Back to top

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire